News

AITX Unveils Exciting New Tech Innovations Ahead of 2025

AITX Unveils Exciting New Tech Innovations Ahead of 2025

Exciting Innovations from AITX as 2025 Approaches

Artificial Intelligence Technology Solutions, Inc. (OTCPK: AITX) has recently provided an exciting glimpse into its upcoming technology launches as the company prepares for a transformative 2025. As a frontrunner in AI-powered security and productivity solutions, AITX, with its subsidiaries Robotic Assistance Devices (RAD-I) and Robotic Assistance Devices Residential, Inc. (RAD-R), is gearing up to roll out significant advancements that promise to reshape how businesses and homes approach safety and operational efficiency.

Major Product Launches on the Horizon

The fourth quarter of fiscal year 2025 heralds an ambitious array of product launches that addresses the evolving needs of both enterprise clients and residential users. This slate includes:

RADCam: Pioneering Security Camera Solutions

One of the highlights is the RADCam, set to begin shipping in December 2024. This innovative, AI-driven interactive security camera is tailored for both residential and small business applications. RADCam is not just a typical security camera; it empowers users to communicate effectively through revolutionary features, making it a game-changer in the home security realm.

SARA Deployments on the Rise

The Speaking Autonomous Response Agent (SARA) platform from RAD-I will commence its initial deployments starting in January 2025. Designed to enhance workforce operations, SARA integrates user-friendly AI-driven access control, improving security protocols while also facilitating user interactions.

AVA Generation 4 with Advanced Features

January 2025 will also usher in the next generation of the AVA (Autonomous Verified Access) system, which will include the Homeowners Association Portal (HOAP). This enhancement will streamline the management of visitors in gated communities and other residential areas, leveraging advanced AI capabilities for improved security measures.

Groundbreaking ROAMEO Demonstrations and RADDOG LE2 Preview

This year, RAD-I will showcase its flagship robotic security device, ROAMEO (Rugged Observation Assistance Mobile Electronic Officer), highlighting its cutting-edge advancements in autonomous navigation and threat detection. These demonstrations, set for February 2025, are anticipated to set a new benchmark in mobile security robotics.

Additionally, a preview of the next-gen robotic canine, RADDOG LE2, is scheduled for March 2025. This innovative device will showcase advanced mobility features, AI interaction, and a rugged design built for law enforcement and critical response scenarios, enhancing operational capabilities in security services.

Annual Investor Presentation Scheduled

Adding to the excitement, AITX is set to host its Annual Investor Presentation on January 15, 2025. This event, streamed live across social media platforms, will feature CEO/CTO Steve Reinharz along with other top executives reviewing the firm’s performance and the strategic vision ahead.

During the presentation, AITX will share insights comparing its previous forecasts with actual outcomes, providing clarity on its financial standing and highlighting growth directives leading into fiscal year 2026.

Revolutionizing Security with AI Technology

AITX continues to redefine the security landscape, representing a rapid shift towards AI-driven solutions in the nearly $50 billion security services industry. By offering robotic technologies that deliver between 35%-80% in cost savings compared to traditional manned guarding services, AITX empowers clients to enhance security protocols without excessive expenditure.

With a growing pipeline including over 35 Fortune 500 companies and numerous new business opportunities on the horizon, AITX's innovative solutions pave the way for an expanding client base. Their technology allows businesses to streamline operations and maintain high levels of safety and security without compromising on quality or economics.

“As we bring forth these revolutionary technologies and broaden our reach, we see limitless potential for both our enterprises and investors,” stated Reinharz. “With future-oriented products like RADCam for home safety and advanced services for corporate clients, we are heading into a new era for AITX.”

Frequently Asked Questions

What new products is AITX launching?

AITX will launch RADCam, SARA platform, AVA Generation 4, ROAMEO Generation 4, and RADDOG LE2 among others.

When is the AITX Annual Investor Presentation?

The Annual Investor Presentation is scheduled for January 15, 2025.

What industries does AITX serve?

AITX technologies are applicable across several sectors including government, transportation, healthcare, and education.

How does AITX's technology improve security systems?

By integrating AI and robotics into security frameworks, AITX enhances efficiency, reduces costs, and provides advanced monitoring capabilities.

Where can I learn more about AITX?

For more details, visit the company’s website at www.aitx.ai.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading